CYBB and colitis: Studies have demonstrated that inhibition of NOX2 activity in mice by using Diphenyleneiodonium chloride (DPI) and VAS2870 (a pan-NOX inhibitor) reduced DSS-colitis in mice, and downregulated pro-inflammatory cytokine secretion in LPS-induced RAW264.7 cells [5,17].